Nanoparticle imaging probes for molecular imaging with computed tomography and application to cancer imaging

Ryan K. Roeder, Tyler E. Curtis, Prakash D. Nallathamby, Lisa E. Irimata, Tracie L. McGinnity, Lisa E. Cole, Tracy Vargo-Gogola, Karen Cowden Dahl

Research output: Chapter in Book/Report/Conference proceedingConference contribution

3 Citations (Scopus)

Abstract

Precision imaging is needed to realize precision medicine in cancer detection and treatment. Molecular imaging offers the ability to target and identify tumors, associated abnormalities, and specific cell populations with overexpressed receptors. Nuclear imaging and radionuclide probes provide high sensitivity but subject the patient to a high radiation dose and provide limited spatiotemporal information, requiring combined computed tomography (CT) for anatomic imaging. Therefore, nanoparticle contrast agents have been designed to enable molecular imaging and improve detection in CT alone. Core-shell nanoparticles provide a powerful platform for designing tailored imaging probes. The composition of the core is chosen for enabling strong X-ray contrast, multi-agent imaging with photon-counting spectral CT, and multimodal imaging. A silica shell is used for protective, biocompatible encapsulation of the core composition, volume-loading fluorophores or radionuclides for multimodal imaging, and facile surface functionalization with antibodies or small molecules for targeted delivery. Multi-agent (k-edge) imaging and quantitative molecular imaging with spectral CT was demonstrated using current clinical agents (iodine and BaSO4) and a proposed spectral library of contrast agents (Gd2O3, HfO2, and Au). Bisphosphonate-functionalized Au nanoparticles were demonstrated to enhance sensitivity and specificity for the detection of breast microcalcifications by conventional radiography and CT in both normal and dense mammary tissue using murine models. Moreover, photon-counting spectral CT enabled quantitative material decomposition of the Au and calcium signals. Immunoconjugated Au@SiO2 nanoparticles enabled highly-specific targeting of CD133+ ovarian cancer stem cells for contrast-enhanced detection in model tumors.

Original languageEnglish (US)
Title of host publicationMedical Imaging 2017
Subtitle of host publicationPhysics of Medical Imaging
PublisherSPIE
Volume10132
ISBN (Electronic)9781510607095
DOIs
StatePublished - 2017
EventMedical Imaging 2017: Physics of Medical Imaging - Orlando, United States
Duration: Feb 13 2017Feb 16 2017

Other

OtherMedical Imaging 2017: Physics of Medical Imaging
CountryUnited States
CityOrlando
Period2/13/172/16/17

Fingerprint

Molecular imaging
Molecular Imaging
Nanoparticles
Tomography
tomography
cancer
Imaging techniques
nanoparticles
probes
Multimodal Imaging
Contrast Media
Neoplasms
Photons
Radionuclide Imaging
radioactive isotopes
counting
Breast
tumors
Radioisotopes
Calcinosis

Keywords

  • Cancer
  • Contrast Agent
  • Molecular Imaging
  • Nanoparticles
  • Photon-Counting Spectral CT
  • Precision Medicine
  • X-ray Computed Tomography

ASJC Scopus subject areas

  • Atomic and Molecular Physics, and Optics
  • Electronic, Optical and Magnetic Materials
  • Biomaterials
  • Radiology Nuclear Medicine and imaging

Cite this

Roeder, R. K., Curtis, T. E., Nallathamby, P. D., Irimata, L. E., McGinnity, T. L., Cole, L. E., ... Cowden Dahl, K. (2017). Nanoparticle imaging probes for molecular imaging with computed tomography and application to cancer imaging. In Medical Imaging 2017: Physics of Medical Imaging (Vol. 10132). [101320X] SPIE. https://doi.org/10.1117/12.2255688

Nanoparticle imaging probes for molecular imaging with computed tomography and application to cancer imaging. / Roeder, Ryan K.; Curtis, Tyler E.; Nallathamby, Prakash D.; Irimata, Lisa E.; McGinnity, Tracie L.; Cole, Lisa E.; Vargo-Gogola, Tracy; Cowden Dahl, Karen.

Medical Imaging 2017: Physics of Medical Imaging. Vol. 10132 SPIE, 2017. 101320X.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Roeder, RK, Curtis, TE, Nallathamby, PD, Irimata, LE, McGinnity, TL, Cole, LE, Vargo-Gogola, T & Cowden Dahl, K 2017, Nanoparticle imaging probes for molecular imaging with computed tomography and application to cancer imaging. in Medical Imaging 2017: Physics of Medical Imaging. vol. 10132, 101320X, SPIE, Medical Imaging 2017: Physics of Medical Imaging, Orlando, United States, 2/13/17. https://doi.org/10.1117/12.2255688
Roeder RK, Curtis TE, Nallathamby PD, Irimata LE, McGinnity TL, Cole LE et al. Nanoparticle imaging probes for molecular imaging with computed tomography and application to cancer imaging. In Medical Imaging 2017: Physics of Medical Imaging. Vol. 10132. SPIE. 2017. 101320X https://doi.org/10.1117/12.2255688
Roeder, Ryan K. ; Curtis, Tyler E. ; Nallathamby, Prakash D. ; Irimata, Lisa E. ; McGinnity, Tracie L. ; Cole, Lisa E. ; Vargo-Gogola, Tracy ; Cowden Dahl, Karen. / Nanoparticle imaging probes for molecular imaging with computed tomography and application to cancer imaging. Medical Imaging 2017: Physics of Medical Imaging. Vol. 10132 SPIE, 2017.
@inproceedings{1244b0e43c41487184ae068437ea9957,
title = "Nanoparticle imaging probes for molecular imaging with computed tomography and application to cancer imaging",
abstract = "Precision imaging is needed to realize precision medicine in cancer detection and treatment. Molecular imaging offers the ability to target and identify tumors, associated abnormalities, and specific cell populations with overexpressed receptors. Nuclear imaging and radionuclide probes provide high sensitivity but subject the patient to a high radiation dose and provide limited spatiotemporal information, requiring combined computed tomography (CT) for anatomic imaging. Therefore, nanoparticle contrast agents have been designed to enable molecular imaging and improve detection in CT alone. Core-shell nanoparticles provide a powerful platform for designing tailored imaging probes. The composition of the core is chosen for enabling strong X-ray contrast, multi-agent imaging with photon-counting spectral CT, and multimodal imaging. A silica shell is used for protective, biocompatible encapsulation of the core composition, volume-loading fluorophores or radionuclides for multimodal imaging, and facile surface functionalization with antibodies or small molecules for targeted delivery. Multi-agent (k-edge) imaging and quantitative molecular imaging with spectral CT was demonstrated using current clinical agents (iodine and BaSO4) and a proposed spectral library of contrast agents (Gd2O3, HfO2, and Au). Bisphosphonate-functionalized Au nanoparticles were demonstrated to enhance sensitivity and specificity for the detection of breast microcalcifications by conventional radiography and CT in both normal and dense mammary tissue using murine models. Moreover, photon-counting spectral CT enabled quantitative material decomposition of the Au and calcium signals. Immunoconjugated Au@SiO2 nanoparticles enabled highly-specific targeting of CD133+ ovarian cancer stem cells for contrast-enhanced detection in model tumors.",
keywords = "Cancer, Contrast Agent, Molecular Imaging, Nanoparticles, Photon-Counting Spectral CT, Precision Medicine, X-ray Computed Tomography",
author = "Roeder, {Ryan K.} and Curtis, {Tyler E.} and Nallathamby, {Prakash D.} and Irimata, {Lisa E.} and McGinnity, {Tracie L.} and Cole, {Lisa E.} and Tracy Vargo-Gogola and {Cowden Dahl}, Karen",
year = "2017",
doi = "10.1117/12.2255688",
language = "English (US)",
volume = "10132",
booktitle = "Medical Imaging 2017",
publisher = "SPIE",

}

TY - GEN

T1 - Nanoparticle imaging probes for molecular imaging with computed tomography and application to cancer imaging

AU - Roeder, Ryan K.

AU - Curtis, Tyler E.

AU - Nallathamby, Prakash D.

AU - Irimata, Lisa E.

AU - McGinnity, Tracie L.

AU - Cole, Lisa E.

AU - Vargo-Gogola, Tracy

AU - Cowden Dahl, Karen

PY - 2017

Y1 - 2017

N2 - Precision imaging is needed to realize precision medicine in cancer detection and treatment. Molecular imaging offers the ability to target and identify tumors, associated abnormalities, and specific cell populations with overexpressed receptors. Nuclear imaging and radionuclide probes provide high sensitivity but subject the patient to a high radiation dose and provide limited spatiotemporal information, requiring combined computed tomography (CT) for anatomic imaging. Therefore, nanoparticle contrast agents have been designed to enable molecular imaging and improve detection in CT alone. Core-shell nanoparticles provide a powerful platform for designing tailored imaging probes. The composition of the core is chosen for enabling strong X-ray contrast, multi-agent imaging with photon-counting spectral CT, and multimodal imaging. A silica shell is used for protective, biocompatible encapsulation of the core composition, volume-loading fluorophores or radionuclides for multimodal imaging, and facile surface functionalization with antibodies or small molecules for targeted delivery. Multi-agent (k-edge) imaging and quantitative molecular imaging with spectral CT was demonstrated using current clinical agents (iodine and BaSO4) and a proposed spectral library of contrast agents (Gd2O3, HfO2, and Au). Bisphosphonate-functionalized Au nanoparticles were demonstrated to enhance sensitivity and specificity for the detection of breast microcalcifications by conventional radiography and CT in both normal and dense mammary tissue using murine models. Moreover, photon-counting spectral CT enabled quantitative material decomposition of the Au and calcium signals. Immunoconjugated Au@SiO2 nanoparticles enabled highly-specific targeting of CD133+ ovarian cancer stem cells for contrast-enhanced detection in model tumors.

AB - Precision imaging is needed to realize precision medicine in cancer detection and treatment. Molecular imaging offers the ability to target and identify tumors, associated abnormalities, and specific cell populations with overexpressed receptors. Nuclear imaging and radionuclide probes provide high sensitivity but subject the patient to a high radiation dose and provide limited spatiotemporal information, requiring combined computed tomography (CT) for anatomic imaging. Therefore, nanoparticle contrast agents have been designed to enable molecular imaging and improve detection in CT alone. Core-shell nanoparticles provide a powerful platform for designing tailored imaging probes. The composition of the core is chosen for enabling strong X-ray contrast, multi-agent imaging with photon-counting spectral CT, and multimodal imaging. A silica shell is used for protective, biocompatible encapsulation of the core composition, volume-loading fluorophores or radionuclides for multimodal imaging, and facile surface functionalization with antibodies or small molecules for targeted delivery. Multi-agent (k-edge) imaging and quantitative molecular imaging with spectral CT was demonstrated using current clinical agents (iodine and BaSO4) and a proposed spectral library of contrast agents (Gd2O3, HfO2, and Au). Bisphosphonate-functionalized Au nanoparticles were demonstrated to enhance sensitivity and specificity for the detection of breast microcalcifications by conventional radiography and CT in both normal and dense mammary tissue using murine models. Moreover, photon-counting spectral CT enabled quantitative material decomposition of the Au and calcium signals. Immunoconjugated Au@SiO2 nanoparticles enabled highly-specific targeting of CD133+ ovarian cancer stem cells for contrast-enhanced detection in model tumors.

KW - Cancer

KW - Contrast Agent

KW - Molecular Imaging

KW - Nanoparticles

KW - Photon-Counting Spectral CT

KW - Precision Medicine

KW - X-ray Computed Tomography

UR - http://www.scopus.com/inward/record.url?scp=85020443926&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020443926&partnerID=8YFLogxK

U2 - 10.1117/12.2255688

DO - 10.1117/12.2255688

M3 - Conference contribution

AN - SCOPUS:85020443926

VL - 10132

BT - Medical Imaging 2017

PB - SPIE

ER -